Please assess the completion status of the following clinical trial:

Trial Title: Lipid Lowering in Patients With Statin Intolerance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~1. Baseline cholesterol - LDL more than 160 with one risk factor or LDL more than 130 with 2 or more risk factors for developing coronary artery disease (Smoker, age \>40, male, Family history, diabetes, obesity) utilizing ATP III guidelines~2. Have had a statin prescribed by a doctor for high cholesterol, and have stopped medication because of side effects~3. Ability to exercise without physical restrictions~4. Ability to attend 12 week consecutive Change of Heart sessions~5. Not taking any cholesterol lowering medication for at least 1 month prior to initiation of trial. Not taking red yeast rice for at least 1 month prior.~Exclusion Criteria:~1. Any active cardiac problem including chest pain, angina, shortness of breath with minimal activity, or unstable angina/acute coronary syndrome within one year~2. Known intolerance to one of the study drugs~3. Physical limitation preventing aerobic exercise program, such as severe arthritis, peripheral vascular disease, congestive heart failure, or symptom limiting pulmonary disease~4. Uncontrolled hypertension (defined as SBP\>180 mmHg or DBP \> 100mmHg.~5. Heart attack, bypass surgery, or angioplasty/stent within 1 year of study~6. Triglyceride level more than 400 mg/dl

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): placebo control
- 2 (Type: ACTIVE_COMPARATOR): red yeast rice

Based on this trial design, predict the completion outcome and termination type (if applicable).